Article Text

PDF

Treatment of paroxysmal disorders in multiple sclerosis with carbamazepine (Tegretol)
  1. Michael L. E. Espir1,
  2. Paul Millac
  1. Department of Neurology, Leicester Royal Infirmary

    Abstract

    During an eight year period, 32 patients with definite or suspected multiple sclerosis (MS) were seen with paroxysmal neurological disturbances, which included tonic seizures, paroxysmal dysarthria, paraesthesiae and pain in the limbs, as well as trigeminal neuralgia. In 21 of these patients the paroxysmal disorders were treated with carbamazepine, and in six the effect was compared with placebo. In the majority carbamazepine was effective in controlling the paroxysmal symptoms. Side-effects were troublesome in a few patients, but they could usually tolerate small doses, which still gave relief. Although the patho-physiological basis for these paroxysmal disorders remains unexplained, their response to carbamazepine suggests a common mechanism.

    Statistics from Altmetric.com

    Footnotes

    • 1 Present address: Regional Department of Neurosurgery and Neurology, Derbyshire Royal Infirmary, Derby.

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.